This novel dynamic culture platform improves cell viability and function in hepatocytes, suggesting advances in tissue engineering.
Background: The engineering of large-scale tissues is frequently hampered by complex, inefficient perfusion bioreactors and the inherent diffusion limits of static culture. To overcome these operational and biological barriers, we developed and validated a novel, user-friendly dynamic culture platform. Methods: Our miniaturized platform seamlessly integrates a peristaltic pump, an oxygenator, and perfusion circuits into a single, easy-to-assemble unit with smart control. We demonstrated its efficacy by culturing AML12 hepatocytes on decellularized rat liver scaffolds for 7 days and comparing its performance against static culture controls. Results: Dynamic culture dramatically enhanced cell viability and functional maturity. Compared to static controls, constructs cultured in our platform exhibited a > 5-fold increase in proliferating (Ki67+) cells and a 32-fold decrease in apoptotic (TUNEL+) cells. Hepatic functions were also significantly enhanced, with increased urea production and markedly higher expression of albumin (∼1.5-fold) and the key metabolic enzymes UGT1 (∼1.4-fold) and CYP2D6 (∼2.7-fold). Conclusion: Our integrated dynamic culture platform provides a simple, reliable, and effective solution for constructing large, viable 3D tissue constructs. By overcoming critical usability and mass transport challenges, this platform represents a powerful and scalable tool for advancing tissue engineering applications, from regenerative medicine to disease modeling.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: